Ganz ML - Search Results

1

Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States.

Keyloun KR, Weber DJ, Gardstein BM, Berger A, Gillard P, Ganz ML. Keyloun KR, et al. Among authors: ganz ml. Hosp Pract (1995). 2018 Dec;46(5):278-286. doi: 10.1080/21548331.2018.1506673. Epub 2018 Aug 21. Hosp Pract (1995). 2018. PMID: 30067108

2

The burden of severe hypoglycemia in type 1 diabetes.

Liu J, Wang R, Ganz ML, Paprocki Y, Schneider D, Weatherall J. Liu J, et al. Among authors: ganz ml. Curr Med Res Opin. 2018 Jan;34(1):171-177. doi: 10.1080/03007995.2017.1391079. Epub 2017 Nov 10. Curr Med Res Opin. 2018. PMID: 29019269

3

The burden of severe hypoglycemia in type 2 diabetes.

Liu J, Wang R, Ganz ML, Paprocki Y, Schneider D, Weatherall J. Liu J, et al. Among authors: ganz ml. Curr Med Res Opin. 2018 Jan;34(1):179-186. doi: 10.1080/03007995.2017.1391080. Epub 2017 Nov 13. Curr Med Res Opin. 2018. PMID: 29017368

4

Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma.

Tran TN, MacLachlan S, Hicks W, Liu J, Chung Y, Zangrilli J, Rubino A, Ganz ML. Tran TN, et al. Among authors: ganz ml. J Allergy Clin Immunol Pract. 2021 Jan;9(1):338-346.e3. doi: 10.1016/j.jaip.2020.06.019. Epub 2020 Jun 20. J Allergy Clin Immunol Pract. 2021. PMID: 32569754 Free article.

5

Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States.

Li Q, Blume SW, Huang JC, Hammer M, Ganz ML. Li Q, et al. Among authors: ganz ml. J Med Econ. 2015;18(12):1020-8. doi: 10.3111/13696998.2015.1067623. Epub 2015 Sep 4. J Med Econ. 2015. PMID: 26134917 Free article.

6

INCORPORATING ENVIRONMENTAL OUTCOMES INTO A HEALTH ECONOMIC MODEL.

Marsh K, Ganz M, Nørtoft E, Lund N, Graff-Zivin J. Marsh K, et al. Int J Technol Assess Health Care. 2016 Jan;32(6):400-406. doi: 10.1017/S0266462316000581. Epub 2017 Jan 9. Int J Technol Assess Health Care. 2016. PMID: 28065172

7

Key data elements for use in cost-utility modeling of biological treatments for rheumatoid arthritis.

Ganz ML, Hansen BB, Valencia X, Strandberg-Larsen M. Ganz ML, et al. J Med Econ. 2015 May;18(5):366-75. doi: 10.3111/13696998.2014.1001848. Epub 2015 Jan 19. J Med Econ. 2015. PMID: 25530467 Free article.

8

Healthcare resource utilization and cost among patients with type 1 diabetes in the United States.

Simeone JC, Shah S, Ganz ML, Sullivan S, Koralova A, LeGrand J, Bushman J. Simeone JC, et al. Among authors: ganz ml. J Manag Care Spec Pharm. 2020 Nov;26(11):1399-1410. doi: 10.18553/jmcp.2020.26.11.1399. J Manag Care Spec Pharm. 2020. PMID: 33119443 Free PMC article.

9

Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia.

Ganz ML, Chavan A, Dhanda R, Serbin M, Yonan C. Ganz ML, et al. J Med Econ. 2021 Jan-Dec;24(1):103-113. doi: 10.1080/13696998.2020.1867443. J Med Econ. 2021. PMID: 33393412 Free article. Updated.

10

The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.

Ganz ML, Sugarman R, Wang R, Hansen BB, Håkan-Bloch J. Ganz ML, et al. Inflamm Bowel Dis. 2016 May;22(5):1032-41. doi: 10.1097/MIB.0000000000000742. Inflamm Bowel Dis. 2016. PMID: 26974852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page